Historical record - last NADAC publication: 1/3/2019
Product Information
OSENI 25-30 MG TABLET is a brand product labeled by Takeda Pharmaceuticals America, Inc., priced at $12.3977 per EA under NDC 64764025303. Its NADAC has been published 318 times since Dec 18, 2013.
Strength
25; 30 mg/1; mg/1
Manufacturer
Takeda Pharmaceuticals America, Inc.NDC
64764025303
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/3/2019
Active Ingredients
ALOGLIPTIN BENZOATE; PIOGLITAZONE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA022426On Market Since
1/25/2013
Pharmacological Classes
Price Statistics
The NADAC for OSENI 25-30 MG TABLET has been published 318 times since Dec 18, 2013, and over the history we have for it it has risen 49.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $12.3977 per EA |
|---|---|
| All-time high | $12.3977 (Jan 15, 2020) |
| All-time low | $8.2705 (Dec 18, 2013) |
| Median price | $11.8059 |
| Average price | $11.2704 |
| Largest weekly change | +9.9% (Aug 12, 2015) |
| Weeks tracked | 318 |
| Tracking since | Dec 18, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the alogliptin and pioglitazone market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of OSENI 25-30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OSENI 25-30 MG TABLET, manufactured by Takeda Pharmaceuticals America, Inc., is $12.3977 per EA (NDC 64764025303), effective Jan 15, 2020.
How has the price of OSENI 25-30 MG TABLET changed over time?
Over the history we have for it, the NADAC for OSENI 25-30 MG TABLET has risen 49.9%. It has been tracked across 318 weekly CMS publications since Dec 18, 2013.
What are the highest and lowest recorded NADAC prices for OSENI 25-30 MG TABLET?
Since Dec 18, 2013, the NADAC for OSENI 25-30 MG TABLET has ranged from a low of $8.2705 (Dec 18, 2013) to a high of $12.3977 (Jan 15, 2020), with a median of $11.8059 per EA.
Are there cheaper alternatives to OSENI 25-30 MG TABLET?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of OSENI 25-30 MG TABLET, so no direct lower-cost alternative is listed.
Who manufactures OSENI 25-30 MG TABLET?
OSENI 25-30 MG TABLET (NDC 64764025303) is labeled by Takeda Pharmaceuticals America, Inc., and CMS classifies it as a brand product.
Related Drugs
Same classification